View Item 

Show simple item record

Modifiable influences on female HPV vaccine uptake at the clinic encounter level: A literature review
dc.contributor.authorSmall, Stephanie L.en_US
dc.contributor.authorSampselle, Carolyn M.en_US
dc.contributor.authorMartyn, Kristy K.en_US
dc.contributor.authorDempsey, Amanda F.en_US
dc.date.accessioned2014-09-03T16:52:10Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-09-03T16:52:10Z
dc.date.issued2014-09en_US
dc.identifier.citationSmall, Stephanie L.; Sampselle, Carolyn M.; Martyn, Kristy K.; Dempsey, Amanda F. (2014). "Modifiable influences on female HPV vaccine uptake at the clinic encounter level: A literature review." Journal of the American Association of Nurse Practitioners 26(9): 519-525.en_US
dc.identifier.issn2327-6886en_US
dc.identifier.issn2327-6924en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108355
dc.description.abstractPurpose A review of the literature to identify modifiable influences on female human papillomavirus (HPV) vaccine uptake relevant to clinical practice in order to support nurse practitioners (NPs) in the prevention of cervical cancer. Data sources PubMed, CINAHL, reference lists of publications that surfaced in the electronic search. Conclusions Six influences are modifiable and potentially amenable to being addressed at the clinic encounter level: (a) cost and insurance coverage, (b) provider recommendation, (c) vaccination opportunity, (d) HPV and HPV vaccine knowledge, (e) vaccine safety concerns, and (f) HPV risk. Implications for practice NPs have an important role in improving HPV vaccine uptake and research suggests several areas they can address to increase vaccination during clinic visits.en_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherImmunizationen_US
dc.subject.otherHuman Papilloma Virus (HPV)en_US
dc.subject.otherVaccinationen_US
dc.subject.otherPreventionen_US
dc.titleModifiable influences on female HPV vaccine uptake at the clinic encounter level: A literature reviewen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelNursingen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108355/1/jaan12057.pdf
dc.identifier.doi10.1002/2327-6924.12057en_US
dc.identifier.sourceJournal of the American Association of Nurse Practitionersen_US
dc.identifier.citedreferenceJain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. ( 2009 ). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, national immunization survey‐adult 2007. Preventive Medicine, 48 ( 5 ), 426 – 431. doi: 10.1016/j.ypmed.2008.11.010en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. ( 2011 ). National and state vaccination coverage among adolescents aged 13 through 17 years—United States, 2010. Morbidity and Mortality Weekly Report, 60 ( 33 ), 1117 – 1123.en_US
dc.identifier.citedreferenceChao, C., Velicer, C., Slezak, J. M., & Jacobsen, S. J. ( 2010 ). Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171 ( 3 ), 357 – 367. doi: 10.1093/aje/kwp365en_US
dc.identifier.citedreferenceConroy, K., Rosenthal, S. L., Zimet, G. D., Jin, Y., Bernstein, D. I., Glynn, S., & Kahn, J. A. ( 2009 ). Human papillomavirus vaccine uptake, predictors of vaccination, and self‐reported barriers to vaccination. Journal of Women's Health, 18 ( 10 ), 1679 – 1686. doi: 10.1089/jwh.2008.1329en_US
dc.identifier.citedreferenceCook, R. L., Zhang, J., Mullins, J., Kauf, T., Brumback, B., Steingraber, H., & Mallison, C. ( 2010 ). Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. Journal of Adolescent Health, 47 ( 6 ), 596 – 599. doi: 10.1016/j.jadohealth.2010.09.015en_US
dc.identifier.citedreferenceDempsey, A. F., Abraham, L. M., Dalton, V., & Ruffin, M. ( 2009 ). Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Annals of Epidemiology, 19 ( 8 ), 531 – 538. doi: 10.1016/j.annepidem.2009.03.011en_US
dc.identifier.citedreferenceDempsey, A., Cohn, L., Dalton, V., & Ruffin, M. ( 2010 ). Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university‐based health system. Vaccine, 28 ( 4 ), 989 – 995. doi: 10.1016/j.vaccine.2009.10.133en_US
dc.identifier.citedreferenceDunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz, L. E. ( 2007 ). Prevalence of HPV infection among females in the United States. Journal of the American Medical Association, 297 ( 8 ), 813 – 819. doi: 10.1001/jama.297.8.813en_US
dc.identifier.citedreferenceGerend, M. A., Weibley, E., & Bland, H. ( 2009 ). Parental response to human papillomavirus vaccine availability: Uptake and intentions. Journal of Adolescent Health, 45 ( 5 ), 528 – 531. doi: 10.1016/j.jadohealth.2009.02.006en_US
dc.identifier.citedreferenceGottlieb, S. L., Brewer, N. T., Sternberg, M. R., Smith, J. S., Ziarnowski, K., Liddon, N., & Markowitz, L. E. ( 2009 ). Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. Journal of Adolescent Health, 45 ( 5 ), 430 – 437. doi: 10.1016/j.jadohealth.2009.03.029en_US
dc.identifier.citedreferenceGuerry, S. L., De Rosa, C. J., Markowitz, L. E., Walker, S., Liddon, N., Kerndt, P. R., & Gottlieb, S. L. ( 2011 ). Human papillomavirus vaccine initiation among adolescent girls in high‐risk communities. Vaccine, 29, 2235 – 2241. doi: 10.1016/j.vaccine.2011.01.052en_US
dc.identifier.citedreferenceInsinga, R. P., Dasbach, E. J., & Elbasha, E. H. ( 2005 ). Assessing the annual economic burden of preventing and treating anogenital human papillomavirus‐related disease in the US: Analytic framework and review of the literature. Pharmacoeconomics, 23 ( 11 ), 1107 – 1122.en_US
dc.identifier.citedreferenceLicht, A. S., Murphy, J. M., Hyland, A. J., Fix, B. V., Hawk, L. W., & Mahoney, M. C. ( 2010 ). Is use of the HPV vaccine among female college students related to HPV knowledge and risk perception? Sexually Transmitted Infections, 86 ( 1 ), 74 – 78. doi: 10.1136/sti.2009.037705en_US
dc.identifier.citedreferenceMathur, M., Mathur, V., & Reichling, D. ( 2010 ). Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. Journal of Pediatric Health Care, 24 ( 1 ), 14 – 24. doi: 10.1016/j.pedhc.2008.11.004en_US
dc.identifier.citedreferenceMoore, G. R., Crosby, R. A., Young, A., & Charnigo, R. ( 2010 ). Low rates of free human papillomavirus vaccine uptake among young women. Sexual Health, 7 ( 3 ), 287 ‐ 290. doi: 10.1071/SH09136en_US
dc.identifier.citedreferenceRand, C. M., Shone, L. P., Albertin, C., Auinger, P., Klein, J. D., & Szilagyi, P. G. ( 2007 ). National health care visit patterns of adolescents. Archives of Pediatric and Adolescent Medicine, 161 ( 3 ), 252 – 259. doi: 10.1001/archpedi.161.3.252en_US
dc.identifier.citedreferenceReiter, P. L., Cates, J. R., McRee, A. L., Gottlieb, S. L., Shafer, A., Smith, J. S., & Brewer, M. T. ( 2010 ). Statewide HPV vaccine initiation among adolescent females in North Carolina. Sexually Transmitted Diseases, 37 ( 12 ), 549 – 556. doi: 10.1097/OLQ.0b013e3181d73bf8en_US
dc.identifier.citedreferenceRosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. ( 2011 ). Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation. Vaccine, 29 ( 5 ), 890 – 895. doi: 10.1016/j.vaccine.2009.12.063en_US
dc.identifier.citedreferenceSchluterman, N. H., Terplan, M., Lydecker, A. D., & Tracy, J. K. ( 2011 ). Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine, 29, 3767 – 3772. doi: 10.1016/j.vaccine.2011.03.032en_US
dc.identifier.citedreferenceSlade, B. A., Leidel, L., Vellozzi, C., Woo, E. J., Hua, W., Sutherland, A., Izurieta, H. S., Ball, R., Miller, N., Braun, M. M., Markowitz, L. E., & Iskander, J. ( 2009 ). Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA, 302 ( 7 ), 750 – 759.en_US
dc.identifier.citedreferenceSmall, S. L., & Patel, D. A. ( 2012 ). Impact of HPV vaccine availability on uptake. Journal for Nurse Practitioners, 8 ( 1 ), 61 – 66.en_US
dc.identifier.citedreferenceZimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., & Vichnin, M. D. ( 2010 ). Reasons for non‐vaccination against HPV and future vaccination intentions among 19–26 year‐old women. BMC Women's Health, 10 ( 27 ), 1 – 6.en_US
dc.identifier.citedreferenceBosch, F. X., Lorincz, A., Muñoz, M., Meijer, C. J., & Shah, K. V. ( 2002 ). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55 ( 4 ), 244 – 265.en_US
dc.identifier.citedreferenceBrewer, N. T., & Fazekas, K. I. ( 2007 ). Predictors of HPV vaccine acceptability: A theory‐informed, systematic review. Preventive Medicine, 45, 107 – 114. doi: 10.1016/j.ypmed.2007.05.013en_US
dc.identifier.citedreferenceBrewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A., Liddon, N., Markowitz, L., & Smith, J. S. ( 2011 ). Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high‐risk geographic area. Sexually Transmitted Diseases, 38 ( 3 ), 197 – 204. doi: 10.1097/OLQ.0b013e3181f12dbfen_US
dc.identifier.citedreferenceCaskey, R., Lindau, S. T., & Alexander, G. C. ( 2009 ). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45 ( 5 ), 453 – 462. doi: 10.1016/j.jadohealth.2009.04.021en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. ( 2007 ). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report, 56 ( RR‐2 ), 1 – 24.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. ( 2010 ). Adult vaccination coverage reported via NHIS. Retrieved from www.cdc.gov/vaccines/stats‐surv/nhis/default.htmen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jaan12057.pdf
Size:
115.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.